# Dr. Louis R. Manara – FDA Inspection, May 23, 2023

Source: https://www.keypedia.com/records/fda_inspections/dr-louis-r-manara/cc9aef08-c3bc-42ad-9fe9-a2851d77a79f
Source feed: FDA_Inspections

> FDA inspection 1206226 of Dr. Louis R. Manara, May 23, 2023. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 1271. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206226
- Company Name: Dr. Louis R. Manara
- Inspection Date: 2023-05-23
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1236701 - 2024-03-26
- FDA Inspection 1152479 - 2021-10-21
- FDA Inspection 1116668 - 2020-01-28
- FDA Inspection 1039896 - 2018-01-12
- FDA Inspection 982516 - 2016-08-18

## Related Officers

- [Company Rep](https://www.keypedia.com/people/emily-a-walters/e80b3581-ffba-4244-9030-b6c9496da932)

Company: https://www.keypedia.com/companies/dr-louis-r-manara/4b0cc23b-4140-4404-b357-4c5e1351800b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
